VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,470 | +2.5% | 14,919 | +14.7% | 0.00% | 0.0% |
| Q2 2023 | $391,580 | +1.2% | 13,005 | +8.7% | 0.00% | 0.0% |
| Q1 2023 | $387,068 | +3.1% | 11,965 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $375,302 | +29.0% | 13,095 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $291,000 | -3.0% | 12,062 | +10.3% | 0.00% | 0.0% |
| Q2 2022 | $300,000 | -31.7% | 10,940 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $439,000 | +6.0% | 11,460 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $414,000 | -6.3% | 12,942 | -13.7% | 0.00% | 0.0% |
| Q3 2021 | $442,000 | -31.0% | 14,992 | -19.0% | 0.00% | 0.0% |
| Q2 2021 | $641,000 | -77.2% | 18,508 | -78.5% | 0.00% | -83.3% |
| Q1 2021 | $2,814,000 | +49.6% | 86,208 | +65.1% | 0.01% | +50.0% |
| Q4 2020 | $1,881,000 | +119.2% | 52,231 | +138.5% | 0.00% | +100.0% |
| Q3 2020 | $858,000 | +121.7% | 21,896 | +107.5% | 0.00% | +100.0% |
| Q2 2020 | $387,000 | +21.3% | 10,550 | -23.8% | 0.00% | 0.0% |
| Q1 2020 | $319,000 | +6.7% | 13,847 | +35.3% | 0.00% | 0.0% |
| Q4 2019 | $299,000 | -93.7% | 10,232 | -94.2% | 0.00% | -92.3% |
| Q3 2019 | $4,732,000 | +1431.4% | 177,190 | +1365.2% | 0.01% | +1200.0% |
| Q2 2019 | $309,000 | +14.0% | 12,093 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $271,000 | +163.1% | 12,093 | +147.5% | 0.00% | – |
| Q4 2018 | $103,000 | +14.4% | 4,887 | 0.0% | 0.00% | – |
| Q3 2018 | $90,000 | -17.4% | 4,887 | 0.0% | 0.00% | – |
| Q2 2018 | $109,000 | -23.2% | 4,887 | -24.5% | 0.00% | – |
| Q1 2018 | $142,000 | -81.9% | 6,470 | -80.8% | 0.00% | -100.0% |
| Q4 2017 | $783,000 | -6.2% | 33,698 | -7.3% | 0.00% | -33.3% |
| Q3 2017 | $835,000 | +11.5% | 36,353 | +7.2% | 0.00% | +50.0% |
| Q2 2017 | $749,000 | -2.5% | 33,925 | +0.7% | 0.00% | -33.3% |
| Q1 2017 | $768,000 | +8.9% | 33,698 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $705,000 | -39.0% | 33,698 | -22.9% | 0.00% | -25.0% |
| Q3 2016 | $1,155,000 | +35.1% | 43,703 | +41.6% | 0.00% | +33.3% |
| Q2 2016 | $855,000 | – | 30,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |